ProVen Growth and Income VCT plc: Issue of Eq...

ProVen Growth and Income VCT plc has announced the allotment of 5,915,423 ordinary shares at an average price of 49.65p per share, based on the net asset value (NAV) as of 30 November 2025, which was adjusted for a recent dividend. This issuance is part of an offer for subscription that opened in November 2025, and the newly allotted shares will rank equally with existing shares. Following this allotment, the total issued share capital and voting rights of ProVen Growth and Income VCT now stand at 327,589,195 ordinary shares. The shares are expected to be admitted to trading on the London Stock Exchange shortly, marking a significant step in the company's capital-raising efforts.

This announcement comes at a time when ProVen Growth and Income VCT is actively seeking to bolster its capital base to support its investment strategy, which focuses on a diversified portfolio of growth-oriented companies. The average issue price of 49.65p represents a slight premium to the NAV of 47.75p per share, indicating that the market has responded positively to the offer. The adjustment for the dividend of 1.25p paid on 30 January 2026 reflects the company's commitment to returning value to its shareholders while also ensuring that the capital raised can be effectively deployed into new investment opportunities.

Financially, ProVen Growth and Income VCT's market capitalisation is now approximately £162 million, based on the post-issue share count and the average issue price. The company has historically maintained a strong balance sheet, and while specific cash balances were not disclosed in this announcement, the successful issuance of shares implies a healthy funding position moving forward. The dilution risk associated with this issuance appears manageable, as the shares were issued at a premium to NAV, which should help mitigate any immediate negative impact on existing shareholders' value.

In terms of valuation, ProVen Growth and Income VCT's current market capitalisation places it within the small-cap tier of the AIM market. To provide context, comparable entities in the same tier include AIM:TRST and AIM:WIX, both of which focus on growth investments and have similar market capitalisations. AIM:TRST has a market cap of approximately £150 million and is trading at a price-to-NAV ratio of around 1.05, while AIM:WIX has a market cap of approximately £175 million with a similar valuation metric. This places ProVen Growth and Income VCT at a competitive valuation, particularly given its recent share issuance at a premium to NAV.

The execution track record of ProVen Growth and Income VCT has been relatively strong, with management historically meeting its investment targets and timelines. However, the company faces specific risks associated with this announcement. The primary risk is the potential for market volatility, which could affect the performance of the underlying portfolio companies in which ProVen invests. Additionally, the success of the capital raise hinges on investor sentiment, which can be unpredictable in the current economic climate.

The next expected catalyst for ProVen Growth and Income VCT will be the admission of the newly issued shares to trading on the London Stock Exchange, which is anticipated to occur shortly. This will provide the company with additional liquidity and allow it to pursue its investment strategy more aggressively.

In conclusion, the announcement regarding the issuance of equity is classified as significant. The successful allotment of shares at a premium to NAV not only strengthens the company's capital position but also reflects positively on investor confidence in ProVen Growth and Income VCT's strategy. The issuance is expected to enhance the company's ability to invest in growth opportunities while managing dilution risk effectively. Overall, this development is a positive step for the company, positioning it well for future growth and investment.

Key insights

• ●5,915,423 shares issued at 49.65p each
• ●Market cap now approximately £162 million
• ●Shares to be admitted to trading soon.

Disagree with this article?